Entera Bio Ltd. Current Tax Liabilities (Deferred)

Current Tax Liabilities (Deferred) of ENTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Current Tax Liabilities (Deferred) growth rates and interactive chart.


Highlights and Quick Summary

Visit stockrow.com/ENTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Current Tax Liabilities (Deferred) of Entera Bio Ltd.

Most recent Current Tax Liabilities (Deferred)of ENTX including historical data for past 10 years.

Interactive Chart of Current Tax Liabilities (Deferred) of Entera Bio Ltd.


Business Profile of Entera Bio Ltd.

Sector: Medical
Industry: Drugs
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product includes the EB612, an oral parathyroid hormone product candidate that has completed a Phase IIa clinical trial for hypoparathyroidism. It is also developing EB613 that has completed Phase I clinical trials for the treatment of osteoporosis and non-union fractures. The company was founded in 2010 and is headquartered in Jerusalem, Israel.